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Abstract 39 
Introduction: Muscle force production is usually impaired in people with spinal cord 40 
injury (SCI). The use of high-intensity neuromuscular electrical stimulation (NMES) strength 41 
training can help promote metabolically active lean muscle mass and thus, increase muscle 42 
mass and improve physical health and quality of life (QoL). Nonetheless, NMES is usually 43 
used at low-stimulation intensities and there is limited evidence on the effects of high-44 
intensity NMES strength training into improving muscle force and mass, symptoms of 45 
spasticity or physical health and quality of life (QoL) in people with SCI. 46 
Methods: Five individuals with chronic SCI completed five 10-repetition sets of 47 
high-intensity knee extension NMES strength training sessions for 12 weeks in both 48 
quadriceps muscles. Quadriceps femoris (QF) knee extensor torque was measured on a 49 
dynamometer and cross-sectional area (CSAQF) was measured with extended-field-of-view 50 
ultrasonography. Venous blood samples were collected for blood lipid profiling and c-51 
reactive protein (CRP) analyses. The Spinal Cord Injury Spasticity Evaluation Tool (SCI-52 
SET) was used to assess symptoms of spasticity and the quality of life index (QLI) SCI 53 
version III was used for QoL measures. 54 
Results: QF tetanic knee extensor torque increased on average by 35% (2 - 92%) and 55 
CSAQF increased by 47% (14 - 145%). A significant increase in the HDL/LDL cholesterol 56 
ratio (p < 0.001), a mean significant improvement of 4.8% ± 2.3% (absolute value = 0.26) in 57 
SCI-SET score was observed, whilst QoL showed a near-significant improvement in the 58 
health & functioning domain (15.0 ± 4.2; 17.3 ± 5.1; p = 0.07). 59 
Keywords: physical health; quadriceps femoris; muscle mass; muscle force; quality of life; 60 
spasticity. 61 
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 62 
Conclusions: High-intensity NMES-strength training in people with SCI may 63 
improve muscle strength, mass, physical health and QoL. However, replication of these 64 
results is necessary before clinical implementation.  65 
 5 
Introduction 66 
  Spinal cord injury (SCI) is a devastating lesion that leads to a marked 67 
reduction in muscle force production and commonly evokes symptoms of spasticity, which 68 
can profoundly impair physical health and quality of life (QoL) (1, 2). Muscle force 69 
production capacity is clearly influenced by skeletal muscle mass (3), which is reduced up to 70 
50% when compared to able-bodied controls (4) and plays a crucial role in reducing the risk 71 
of premature all-cause mortality (5). Thus, people with SCI are at a higher risk of developing 72 
cardiovascular diseases and dyslipidemia (6) and are thus faced with decreased life 73 
expectancy (7, 8). 74 
Muscle strength training stimulates gains in muscle mass and strength, reduces 75 
systemic inflammation and enhances longevity and QoL (9-11). More specifically, high-76 
intensity strength training, which refers to the imposition of sufficient loading to evoke near-77 
maximal motor unit activation (12), can impose a strong mechanical stimulus that enhances 78 
the hypertrophic response and generates optimum muscle strength gains (13) leading to 79 
physical health benefits (14). However, such training may not be feasible in patients with 80 
neuromuscular injury or disease, such as those with SCI, who may not be able to sufficiently 81 
activate the muscles to generate the necessary forces during training. In these individuals, 82 
neuromuscular electrical stimulation (NMES) methods have been used, commonly in the 83 
form of functional electrical stimulation (FES), to overcome muscle weakness and improve 84 
muscle strength and mass with the consequent benefits in physical health (15-17). 85 
Nonetheless, the intensity of muscle contraction is low during FES and optimum hypertrophy 86 
and other outcomes are not obtained. Whilst the use of NMES as a strength training modality 87 
has previously been shown to stimulate muscle hypertrophy (16, 18-20), the use of NMES as 88 
a high-intensity strength training mode has not been extensively investigated and, due to the 89 
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limited evidence supporting its use for increasing muscle strength (21, 22) is not commonly 90 
used in clinical practice. Importantly, some essential outcomes, such as muscle force and 91 
physical health improvements, muscle and bone plasticity (23, 24) effects on intramuscular 92 
fat (4, 25) and symptoms of spasticity and QoL, have not been extensively explored in people 93 
with SCI undertaking NMES strength training interventions (21, 26) and specifically in 94 
response to high-intensity muscle strength training. Furthermore, there is a lack of evidence 95 
relating to the use of isometric (27), near-maximal (high-intensity) short duration (2-s) 96 
muscle contractions and a wide-pulse width (1000 µs) in people with SCI. Thus, a larger 97 
body of work is required to more clearly define the adaptations to NMES-high intensity 98 
strength training to allow for clearer cost-benefit decisions by clinicians. 99 
Therefore, the purpose of the present study was to investigate the effects of high-100 
intensity strength training performed under isometric conditions using low-to-moderate-101 
frequency (30 Hz) NMES (i.e. standard clinical conditions) on muscle force and mass, 102 
physical health, symptoms of spasticity and QoL in people with SCI. The hypothesis was that 103 
12-weeks of high-intensity strength training performed under isometric conditions using low-104 
to-moderate-frequency (30 Hz) NMES will improve muscle force and mass, physical health, 105 
symptoms of spasticity and QoL in people with SCI.  106 
 Methods 107 
Subjects 108 
Five subjects (4 males, 1 female; see Table 1 for subject’s characteristics: subject’s 109 
levels of injury, completeness of lesion, time since injury, AIS scale score, medication type 110 
and, wheelchair user or community walker and use of functional electrical stimulation (FES) 111 
routinely) completed a 12-week intervention. Prior to the study, the subjects were given 112 
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detailed information about the procedures and risks of participation and then read and signed 113 
a written informed consent document. The subjects completed the Physical Activity 114 
Readiness Questionnaire (PAR-Q), provided a medical certificate to ensure safe exercise 115 
participation, and refrained from vigorous exercise (48 h), alcohol (24 h) and stimulant 116 
consumption (e.g. caffeine, energy drinks, 6 h) prior to testing. Subjects were asked to 117 
replicate the same physical activities for each session. This study was approved by the Edith 118 
Cowan University Ethics Committee (project number: 11623). 119 
Procedures 120 
The study duration was 14 weeks and assessments were performed identically on 121 
three different occasions at the same time of the day and under the same experimental 122 
conditions. In the first two weeks of the study the subjects completed a control phase where 123 
they did not perform any experimental training but continued their regular physical activities. 124 
This followed a familiarisation session performed the week before the first training session. 125 
Training was performed twice a week (with at least one rest day in between) for 12 weeks. 126 
All assessments were completed at -1 week (“Control period”), 0 week (0-wk) and 12 weeks 127 
(12-wk), except for resting blood samples which were taken at 0-wk and 12-wk only. Post-128 
training assessments were taken 4-6 days after the last training session to allow for recovery 129 
of acute, residual effects of intense exercise. The procedures used in this study were similar 130 
from the methodology used in a previous study in healthy individuals (28) and adapted for 131 
people with SCI. 132 
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Outcome measures 133 
Knee-extension torque measurements (NMES protocol) 134 
Subjects were seated with hip and knee joint angles of 85o and 90o, respectively (0 135 
o=full extension), with the thigh and trunk secured to a standard dynamometer chair (Biodex 136 
System 3 Pro, Ronkonkoma, NY) and the knee joint aligned with the centre of rotation of the 137 
dynamometer. If any voluntary contractions were visualized and a torque recorded, then a 138 
standardised warm-up protocol was performed. However, if no voluntary contraction was 139 
observable then the subjects were instructed to attempt three maximal voluntary isometric 140 
contractions (MVICs) with no additional warm-up efforts. This method was used because all 141 
subjects were instructed to consciously think about performing an MVIC in the knee 142 
extensors for 3 seconds and relax to be consistent among the whole cohort of participants.  143 
Subsequently, two electrical square-wave stimuli (two 1000-µs square-wave pulses 144 
with 5-ms interpulse interval) were delivered to the subjects’ right and left legs by a high-145 
voltage constant-current electrical stimulator (400 V, DS7A, Digitimer Ltd., Welwyn Garden 146 
City, UK) every 20 s, increasing in current from 30 to 99 mA in 10-mA increments until a 147 
plateau in the peak twitch (doublet) torque was observed. This was defined as the maximal 148 
peak twitch torque (ttw,p) and was used as the “target torque” during the subsequent training 149 
session. A second, submaximal twitch torque (ttw,sub) recording was obtained at a current 150 
intensity of 40 mA. Subsequently, a maximum of three NMES trains were provided at 151 
different stimulation (current) intensities until reaching the closest value to the target torque. 152 
The NMES protocol consisted of repeated 30-Hz trains of 58 symmetric biphasic pulses 153 
(0.033-s inter-pulse interval; 1000 µs) and the inter-train interval was 2 s (i.e. 2-s on and 2-s 154 
off).  155 
 9 
Muscle cross-sectional area (CSA)  156 
Quadriceps femoris (QF) CSA was measured using B-mode axial-plane 157 
ultrasonography (Aloka SSD-α10, software 6.1.09, Aloka Co., Ltd., Tokyo, Japan). Subjects 158 
rested supine for 15 min before testing to minimise fluid shifts before images were captured 159 
with a 10 MHz linear-array probe (60-mm width) using the extended field-of-view technique 160 
(EFOV; (29)). A line from the central point of the patella to the medial aspect of the anterior 161 
superior iliac spine (ASIS) was marked to obtain the images (29). One line perpendicular to 162 
this was marked at 50% of the distance from the greater trochanter to the lateral epicondyle 163 
(29). Two continuous single view scans were then obtained by moving the probe transversely 164 
across the thigh on the marked line. Minimal pressure was applied with the probe to avoid 165 
compression of the muscle. CSAQF was measured using ImageJ digitising software (1.46r, 166 
Wayne Rasband, National Institutes of Health, USA) for the whole quadriceps femoris (QF) 167 
with the mean of the two images taken as CSAQF.  168 
Blood biomarkers for blood lipid profile and CRP concentration 169 
Resting venous blood samples were collected from a superficial vein on the 170 
antecubital aspect of the arm. A needle and vacutainer setup were used with the subject 171 
seated following a 12 h overnight fast, blood samples were collected at the same time of day 172 
on each testing occasion. Whole blood samples were collected in 5-ml serum separator (SST) 173 
vacutainers. The SST sample was centrifuged for 15 min at 5,000 rpm, with 500 µL aliquoted 174 
and stored at -80oC before being sent to a local pathology laboratory for blood lipid profiling 175 
and c-reactive protein (CRP) analysis. 176 
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Spasticity and quality of life (QoL) measures 177 
The Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET) (30) was used to obtain 178 
subjective and objective measures of symptoms of spasticity and how these interfere with 179 
specific areas of life. The quality of life index (QLI) SCI version III (31) was used to obtain 180 
measures of both satisfaction and importance regarding various aspects of life. 181 
Muscle strength training intervention: electrical stimulation and training 182 
progression (NMES training-intervention) 183 
NMES was delivered by a high-voltage constant-current electrical stimulator (400 V, 184 
DS7A, Digitimer Ltd., Welwyn Garden City, UK) under the same conditions as the 185 
assessment (refer to “Knee extension torque measurements” section) through four self-186 
adhesive stimulation electrodes (Axelgaard, PALS, USA) placed over the rectus femoris 187 
(RF), vastus lateralis (VL), and vastus medialis (VM). Two 5×10 cm electrodes were placed 188 
over RF and one 5×5 electrode was placed on each of the VM and VL approximately at their 189 
motor points using a split end cable (outlet cable which delivered current through 2 190 
electrodes emanating from each positive and negative terminal on the stimulator), to increase 191 
the surface area of stimulation. The electrodes were placed to elicit the greatest twitch 192 
response with a low stimulation intensity. Long quadriceps muscle length was chosen to elicit 193 
greater hypertrophy (27). 194 
Each session commenced with a “warm-up” period consisting of paired electrical 195 
square-wave stimuli (two 1000 µs square-wave pulses, 5–ms interpulse interval) followed by 196 
a maximum of three tetanic trains (tt,40mA) delivered to each leg separately every 20 s while 197 
the stimulation current was increased from 30 mA in 10-mA increments until a plateau in the 198 
maximum peak twitch torque was observed or the maximal current intensity was 99 mA. This 199 
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plateau was defined as the maximal peak twitch torque (ttw,p) and was used as the target 200 
torque during the training session. Subsequently, a tetanic train of NMES at 40 mA (tt,40mA) 201 
was delivered followed by a maximum of three trains of NMES performed at different 202 
stimulation current intensities until reaching the closest value to the target torque. These 203 
assessments were repeated at the beginning of every NMES training session to assess the 204 
level of the current needed to evoke a near-maximal muscle contraction.  205 
After the warm-up period the NMES session commenced with electrically-evoked 206 
muscle contractions being elicited at the target torque for 5 sets of 10 repetitions on each leg, 207 
with a 1-min rest between sets (duty cycle 2s on-2 s off). To determine the actual training 208 
intensity either one of two methods was used. The first method was by evoking the maximal 209 
peak twitch torque (ttw,p) and setting the current so the tetanic torque was equal to ttw,p. 210 
However, if ttw,p showed a decrease compared to previous sessions, a second method was 211 
used whereby the starting current was set to be equal to the highest current used in the 212 
previous training session. Within each session, the current was increased by 2 mA per each 213 
set of 10 repetitions to maintain a high torque production as fatigue developed; thus, if the 214 
second method was chosen, the current selected for set 1 was the same as that used in the 215 
final set of the previous session. Using this method, the torque produced in set 1 of training 216 
was always higher than that performed in any set of the previous session, so the evoked 217 
torque increased incrementally. 218 
The training volume progression was based on the total torque-time integral (TTI) 219 
over the 24 sessions. Maximum levels of torque evoked in the first contractions during the 220 
first week of training (i.e. between 0 and 1 wk) and in the last five contractions during the last 221 
week of training (between 11 and 12 wk) were calculated for analysis of training progression 222 
and to measure the levels of work capacity over the weeks of training. 223 
 12 
All training sessions were conducted by the same trained researcher, who was a senior 224 
Physiotherapist and were additional to any other rehabilitation exercise. The subjects were 225 
asked to keep their physical training routine consistent for the duration of the experiment. All 226 
subjects were asked to consciously attempt to contract their QF muscles while the NMES 227 
protocol was being delivered, due to evidence showing that consciously thinking about 228 
moving a part of the body activates a part of the cerebral cortex and may allow for a better 229 
sensory integration of the information (32). 230 
Statistical analysis 231 
Wilcoxon non-parametric tests were used to separately examine changes in control 232 
and experimental periods (-1 and 0: control period and between 0 and 12-weeks: 233 
intervention) in peak twitch torque (ttw,p), evoked tetanic torque (tt,40mA), cross-sectional area 234 
(CSAQF), body composition, biochemical measures for lipid profile and CRP, symptoms of 235 
spasticity and QoL outcomes. Reliability of the outcome measures between the control period 236 
(-1-wk) and 0-wk was assessed using the intra-class correlation coefficient (ICC). Values are 237 
reported as mean ± SD and statistical significance was set at an alpha level of 0.05; however, 238 
due to the moderate sample size used and issues surrounding the use of stringent cut-off 239 
limits, results associated with p values <0.1 are also highlighted as near-significant. 240 
We certify that all applicable institutional and governmental regulations concerning 241 
the ethical use of human volunteers were followed during this research. 242 
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 Results  243 
Muscle strength: peak twitch torque (ttw,p) and evoked tetanic torque (tt,40mA) 244 
Although mean maximal peak knee extensor twitch torque (ttw,p; sum of right and left 245 
quadriceps; QF) did not change significantly (p=0.08) between 0-wk (50.4±14.3 Nm) and 12-246 
wk (44.8±11.7), QF evoked tetanic torque (tt,40mA) showed a significant increase of 247 
31.8±24.8% between 0 and 12-wk (from 0-wk: 44.2 ± 15.0 Nm to 12-wk: 56.7±17.4 Nm; 248 
p=0.04, Z score=-2.0) (see Figure 1). The intra-class correlation (ICC) coefficient for ttw,p for 249 
the right leg was 0.96 and for left leg 0.87 when assessed between -1 and 0-wk. The level of 250 
torque developed during ‘fatigue’ at the end of the training period was statistically greater 251 
(35.2±27.9 Nm) than the non-fatigued torque developed in week 1 (29.1±20.2 Nm). Mean 252 
TTI at session 24 was statistically greater than week 1 (percentage difference: 126±131%; 253 
p=0.03). 254 
Muscle cross-sectional area (CSAQF)  255 
Mean quadriceps femoris CSA (CSAQF, sum of right and left legs) increased by 256 
45±25% (p=0.04, Z score=-2.0) from 0-wk (80.0±33.8 cm2) to 12-wk (113.1±42.8 cm2) (see 257 
Figure 2A). Between-subject differences were qualitatively observed, where the greatest 258 
response (increase in CSAQF of 145%, right leg), was observed in subject E who had not been 259 
exposed to electrical stimulation training previously, whereas the least response (increase of 260 
15%, right leg) was observed in subject C with an incomplete lesion (T12, AIS D) who was a 261 
community walker (walked with one crutch). The intra-class correlation (ICC) coefficients 262 
for ttw,p for both right and left leg separately were 0.99 between -1-wk and 0-wk. An example 263 
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of the cross-sectional area (CSAQF) of the (left) quadriceps measured in subject A at 0-wk 264 
and 12-wk using extended-field-of-view ultrasonography can be found on Figure 2B. 265 
Blood biomarkers for blood lipid profile and CRP 266 
A near-significant decrease in low density lipoprotein concentration (p=0.06; Z 267 
score=-1.8) and a significant increase in the cholesterol HDL/LDL ratio (p=0.04; Z score=-268 
2.0) were observed, whilst a near-significant decrease in cholesterol/HDL ratio (p=0.08; Z 269 
score=-1.7) was detected. Plasma c-reactive protein (CRP) concentration did not change 270 
significantly (p=0.50; Z score=-0.6) however two subjects with CRP concentrations higher 271 
than the recommended levels showed clear reductions after the 12-wk of training (subject A: 272 
73% decrease; subject E: 95% decrease). Mean changes in blood biomarkers are shown in 273 
Table 2 (blood biomarkers at 0-wk and 12-wk and percent change within group). 274 
Spasticity symptoms and quality of life (QoL) 275 
Symptoms of spasticity measured using the spasticity evaluation tool (SCI-SET 7-day 276 
recall: positive vs negative effects of spasticity; -3-+3) were significantly reduced by 5%±2% 277 
(0-wk: -0.7±0.4; 12-wk: -0.4±0.3; p=0.04; Z score=-2.0, see Figure 3: seven-day recall score 278 
at -1, 0 and 12 weeks).  279 
The Quality of life index (QLI) for SCI version III total score (QLI) and subscales 280 
domains did not change significantly from 0-wk to 12-wk. However, there was a near- 281 
significant change towards an improvement in the health & functioning domain (0-wk: 282 
15.0±4.2; 12-wk: 17.3±5.1; p=0.08, Z score=-1.7). The intra-class correlation coefficients 283 
were 0.94 for QLI, 0.97 for HF, 0.85 for SOC, 0.87 for FAM and 0.97 for PSP when 284 
measured from -1-wk and 0-wk. Subject C and D showed a change in QLI greater (20% and 285 
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16%, respectively) than the mean percentage difference from -1 and 0-wk (12%) and thus 286 
showed notable responses. 287 
Discussion 288 
The main results of this study are that high-intensity NMES strength training induced 289 
substantial increases in evoked tetanic knee extensor torque (i.e. muscle strength) and 290 
quadriceps cross-sectional area (i.e. muscle size). These changes were observed even in 291 
subjects who also used other forms of electrical stimulation-based training (e.g. FES) 292 
regularly. It was of specific interest that the mean evoked torque increased from 0-wk to 12-293 
wk. This result was also evidenced by the evoked torque measured in the last contractions in 294 
the final week, which were either equal to or higher in all subjects than the first contractions 295 
in the first week. These results in evoked torque revealed a notable increase in muscle work 296 
capacity in paralysed muscles after the high-intensity NMES strength training intervention. 297 
Another interesting observation was that tetanic muscle force (QF tetanic torque (tt,40mA)) 298 
increased significantly whilst mean maximal peak twitch torque (ttw,p) did not change 299 
significantly. One possibility is that ttw,p can be affected by factors such as series elastic 300 
component stiffness or changes in the relationship between Ca2+ release and force production 301 
in  paralysed muscle, and thus may not be a reliable longitudinal measure of muscle force 302 
(33) particularly in clinical populations. Nonetheless, the substantial (mean=32%) increases 303 
in tetanic torque revealed a clear improvement in muscle force generating capacity after the 304 
training. 305 
A large (mean=45%) increase in CSAQF was observed, which is clinically important 306 
since the muscle atrophy that is typically associated with chronic SCI has detrimental effect 307 
on metabolic, cardiovascular and functional systems (6) which meaningfully impact life 308 
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expectancy (6, 34). Previous researchers have reported less increase (20%) after an 8-week 309 
intervention (19) and others reported similar large increases in CSA after NMES training 310 
(35%-45%) after 12 to 24 weeks of training, albeit using different pulse widths (250/600 µs) 311 
at similar frequencies (30-35 Hz) (16, 18, 20, 35). Thus, our training stimulated the same 312 
increase in CSA (45%) in 12 weeks as others have obtained after a similar period using 313 
currents up to 200 mA (18), although the maximum current intensity in our study being 99 314 
mA. This improvement in CSAQF with lower current intensities may speculatively be 315 
attributed to three important differences in the present study: (a) the use of isometric rather 316 
than concentric contractions that were performed at a long muscle length (27), (b) the use of 317 
near-maximal muscle contractions that could be performed with less fatigue due to the short 318 
duration (2-s) contractions when compared to other studies (e.g. 5-s contractions), and (c) the 319 
use of wide-pulse width NMES (1000 µs) instead of narrow pulses widths. The use of 320 
isometric contractions may have generated higher muscle forces at a given activation level 321 
and therefore a greater mechanical load would have stimulated muscle hypertrophy (36). 322 
Two-second contractions were chosen as optimal after pilot testing results, and thus used in 323 
the present study to allow for higher stimulation intensities to be used without the 324 
development of rapid muscle fatigue. Thus, this type of contraction at a long muscle length 325 
may speculatively be a main factor driving the positive outcomes; however, this hypothesis 326 
needs to be more explicitly examined in future studies by comparing adaptations to training 327 
using different exercise protocols. Finally, the use of wider pulse widths could have 328 
generated muscle contractions through central mechanisms (i.e. using Ia afferents) and, thus 329 
may have generated higher forces or delayed muscle fatigue (37, 38). However, further 330 
testing of the specific effects of each training variable is needed to provide valuable and 331 
informative information for future clinical implementation. 332 
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Changes in blood-based biomarkers of physical health were observed, including a 333 
significant decrease in LDL and an increase in HDL/LDL ratio. These improvements in 334 
physical health outcomes are thought to be associated with an increased life expectancy in 335 
people with SCI (6). Similar findings of improvement in the lipid profile were previously 336 
reported (11, 35), however, in contrast with the findings of Gorgey, changes in total 337 
cholesterol levels and triglycerides were not found in the current study. As dietary intake was 338 
not strictly controlled, it is not possible to determine whether nutritional factors influenced 339 
this result, however it is also possible that additional muscle groups allowed for greater 340 
systemic changes to be elicited. Additionally, two subjects with initial high CRP 341 
concentration levels obtained normal CRP levels after the intervention in the current study. 342 
This result might suggest a protective effect of the muscle contractions evoked by high-343 
intensity NMES strength training, which promotes anti-inflammatory myokine release and 344 
may attenuate low-grade inflammation reducing cardiovascular disease risk (9, 39). However, 345 
other more specific markers, such as interleukin 6 (IL-6) (9), should be included in future 346 
studies to better understand the metabolic response. Possibly longer duration interventions or 347 
targeting more muscle groups in combination with a controlled diet intake may evoke robust 348 
reductions in systemic inflammation. 349 
Of final note, an important finding of the present study was that the subjects reported 350 
improvements in their symptoms of spasticity. This relevant finding emphasises the potential 351 
benefits of high-intensity NMES strength training for improving the perception of spasticity 352 
symptoms, which represents a negative influence in QoL in people with SCI (2). However, 353 
no overall improvements in QoL were reported and the change observed in the spasticity 354 
symptoms may not be clinically significant (30). Nonetheless, a near-significant value was 355 
observed toward an increase in the health and functioning subscale of the QoL index (0-wk: 356 
15.0±4.2; 12-wk: 17.3±5.1; p=0.07) and two subjects showed a change in QLI score greater 357 
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(20% and 16%) than the mean percentage difference observed from -1 and 0-wk (12%), 358 
indicating clear improvements. In future, it will be important to understand the perceptions of 359 
people with SCI of feeling physically active and experiencing muscle contractions of the 360 
paralysed muscles (40). As an example of this, one subject who was a former competitive 361 
surfer expressed that he that he was enjoying having a “leg day at the gym” as he used to 362 
have before his injury. Thus, the present results provide evidence that the high-intensity 363 
NMES strength training intervention had a positive impact on the subject’s perceptions of 364 
their physical disability. 365 
Limitations of this study included the absence of a non-training control group, due to 366 
the difficulty in recruiting people with SCI into a study where no intervention is given, and 367 
moderate sample size. It would be of great scientific benefit if larger, controlled studies could 368 
be conducted in the future to test the findings of the current study. 369 
Conclusion 370 
Twelve weeks of high-intensity NMES strength training of the knee extensor muscles 371 
increased evoked tetanic knee extensor torque (i.e. muscle strength) and quadriceps cross-372 
sectional area (i.e. muscle size). Subjects reported reduced symptoms of spasticity. Despite 373 
this, however, no overall improvement in QoL was reported, although a near-significant 374 
value was observed toward an increase in the health and functioning subscale in the QLI and 375 
positive, subjective comments were received from the subjects. High-intensity NMES 376 
strength training may be effective for improving muscle force and mass and decreasing 377 
perceived symptoms of spasticity, and can be safely implemented in people with SCI. Some 378 
evidence also indicated improvements in physical health and quality of life. However, 379 
replication of these results in a larger sample of subjects and with a non-training control 380 
group is necessary before its implementation in clinical practice.  381 
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Title and legends to figures and tables: 
Title and legends to figures: 
Fig. 1. QF evoked tetanic torque (tt,40mA) measured at 0 and 12-wk 
Isometric knee extensor torque (QF; sum of right and left quadriceps) at weeks 0 and 12 
(0-wk, 12-wk). QF evoked tetanic torque (tt,40mA) showed a significant increase of 
31.8±24.8% between 0 and 12-wk. 
 Grey dashed lines represent individual subjects whilst the black solid line represents 
the group mean. Inset: Percentage change in evoked isometric knee extensor torque 
(QF) from 0-wk to 12-wk. * Significantly different between 0-and 12-wk (p<0.05). 
Fig. 2. 
 A- Cross-sectional area of the quadriceps (CSAQF) 
Total cross-sectional area of the sum of right and left quadriceps at 0-wk and 12-wk. 
CSAQF increased significantly (p=0.04) by 45.0 ± 25.8% between 0 and 12-wk.  
Grey, dashed lines represent individual subjects whilst black, solid line represents the 
group mean. Inset: Percentage change in CSAQF. * Significantly different from 0-wk and 
Control (p<0.05).  
 B- Cross-sectional area ultrasound image using extended-field of view 
technique 
Example of the cross-sectional area (CSAQF) measurement of the (left) quadriceps 
measured in subject A at 0-wk and 12-wk using extended-field-of-view 
ultrasonography. A significant increase of 45.0 ± 25.8% was observed (mean ± SD) in 
the group of 5 subjects. 
 
Fig. 3. Spasticity evaluation tool (SCI-SET) results 
Seven-day recall score (-3-+3) at -1, 0 and 12 weeks. A significant reduction of 
4.8%±2.3% was observed.  
* Significantly different at 12-wk from 0 and -1-wk (p<0.05). Grey, dashed lines 
represent individual subjects whilst black, solid line represents the group mean. 
Title and legends to tables: 
Table 1: Subject’s characteristics  
Subject’s levels of injury, completeness of lesion, time since injury, AIS scale score, medication type and, 
wheelchair user or community walker and use of functional electrical stimulation (FES) routinely. 
Table 2: Blood lipid profile and CRP concentration 
Blood biomarkers at 0-wk and 12-wk and percent change within group (mean ± SD). 
 
